Recent advances in the use of radiosensitizing nucleosides
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 11 (4) , 270-280
- https://doi.org/10.1053/srao.2001.26002
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Phase I Study of Preoperative Oral Uracil and Tegafur Plus Leucovorin and Radiation Therapy in Rectal CancerJournal of Clinical Oncology, 2000
- A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer.International Journal of Radiation Oncology*Biology*Physics, 2000
- Oral fluoropyrimidines in cancer treatment.Cancer Investigation, 2000
- Phase II study of radiochemotherapy with uft and low-dose oral leucovorin in patients with unresectable rectal cancerInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.Journal of Clinical Oncology, 1998
- Fluoropyrimidine-radiation interactions in cells and tumorsSeminars in Radiation Oncology, 1997
- Patient preferences for oral versus intravenous palliative chemotherapy.Journal of Clinical Oncology, 1997
- The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitizationInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958)Cancer Treatment Reviews, 1980